Therapeutic warfarin dose dependence on age and smoking in acute pulmonary embolism

Jolita Rackauskiene (Vilnius, Lithuania), Jolita Rackauskiene, Vaida Gedvilaite, Mindaugas Mataciunas, Mazvile Abrutyte, Olga Kusner, Edvardas Danila

Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Session: Healthcare organisation and appropriateness in lung disorders
Session type: Thematic Poster Session
Number: 700

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jolita Rackauskiene (Vilnius, Lithuania), Jolita Rackauskiene, Vaida Gedvilaite, Mindaugas Mataciunas, Mazvile Abrutyte, Olga Kusner, Edvardas Danila. Therapeutic warfarin dose dependence on age and smoking in acute pulmonary embolism. Eur Respir J 2015; 46: Suppl. 59, 700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral and inhaled corticosteroid use has a time-dependent association with recurrent pulmonary embolism
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Global fibrinolytic profile in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Clinical profile and mortality of patients with pulmonary embolism and cancer
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

Hemorrhagic complications of treatment in patients with pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Prognostic role of excessive exercise ventilation in non-operable patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016


Tobacco smoke in patients with pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Smoking patterns in patients following a pulmonary embolism
Source: Eur Respir J 2009; 33: 942-943
Year: 2009


Pulmonary embolism: Diagnosis and mortality in patients with COPD
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015


Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


Interest of check-up before discontinuing anti thrombotic therapy after a first episod of pulmonary embolism
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013


The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Asthma and the risk of pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism
Source: Eur Respir J 2013; 41: 354-359
Year: 2013